Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

DSpace Repository

Show simple item record

dc.contributor.author Gallwitz, Baptist
dc.date.accessioned 2023-05-23T09:16:04Z
dc.date.available 2023-05-23T09:16:04Z
dc.date.issued 2022
dc.identifier.issn 1664-2392
dc.identifier.uri http://hdl.handle.net/10900/141344
dc.language.iso en de_DE
dc.publisher Frontiers Media Sa de_DE
dc.relation.uri http://dx.doi.org/10.3389/fendo.2022.1004044 de_DE
dc.subject.ddc 610 de_DE
dc.title Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity de_DE
dc.type Article de_DE
utue.quellen.id 20230202000000_00883
utue.personen.roh Gallwitz, Baptist
dcterms.isPartOf.ZSTitelID Frontiers in Endocrinology de_DE
dcterms.isPartOf.ZS-Issue Article 1004044 de_DE
dcterms.isPartOf.ZS-Volume 13 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record